Free provider profile
ROBERT FREELE, M.D.
NPI 1851317101
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2015-04-16.
7777 FOREST LN C-833, DALLAS, TX, 75230
972-566-4591
Single practice location
Enumerated 2006-07-13
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 1 payer identifiers on file — enrolled with payers.
- — Record last updated 11 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
2,958
Medicare patients
391
Part D drug cost
$1,024,765
Brand-name share
11.2%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Austedo (Deutetrabenazine) | 34 | $452,628 |
| Ingrezza (Valbenazine Tosylate) | 26 | $215,633 |
| Invega Sustenna (Paliperidone Palmitate) | 29 | $84,758 |
| Vyvanse (Lisdexamfetamine Dimesylate) | 75 | $33,205 |
| Belsomra (Suvorexant) | 53 | $23,183 |
| Lisdexamfetamine Dimesylate (Lisdexamfetamine Dimesylate) | 72 | $16,467 |
| Trintellix (Vortioxetine Hydrobromide) | 21 | $14,811 |
| Suboxone (Buprenorphine Hcl/Naloxone Hcl) | 16 | $11,415 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024102 sessions · 11 patients · $99,069
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.